Chinese researchers at Westlake University have developed a handheld device that detects early-stage cancer biomarkers from a single drop of blood with unprecedented accuracy.

The new system is about 10,000 times more sensitive than traditional methods at detecting early-stage lung cancer.

Prototype achieves diagnosis accuracy of up to 95 per cent, researchers say